Global Market Watch:Global Cardiac Pacemaker sector is projected to reach US$5.7 billion by 2016. The North American segment accounts for nearly 40% (2015) of the global market share while Europe claims approximately 30% (2018). Asia-Pacific is the fastest growing region with a CAGR of 11.4% driving a market value of US$728 million by 2015. On a global scale, projections for Implantable Pacemakers market share indicates more than 50% by 2015 leaving the rest of the market to the External Pacemakers.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

The period considered for the cardiac pacemakers devices market analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific)), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 133 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVECARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMYIMPACT OF CVD IN EUROPEIMPACT ON NEW YORK STATEECONOMIC IMPACT OF CVD IN NYSHEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTIONIMPACT OF CVD ON ECONOMIC STABILITY